Current opinions on the role of pathogen reduction technology in improving the viral safety of blood and derivatives

被引：0
|
作者：
Seghatchian, Jerard [1 ]
机构：
[1] Blood Components Apheresis Technol & Haemostasis, London NW3 3AA, England
来源：
TRANSFUSION AND APHERESIS SCIENCE | 2008年 / 39卷 / 01期
关键词：
D O I：
10.1016/j.transci.2008.05.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：49 / 50
页数：2
相关论文
共 50 条
  • [1] Improving blood safety and patient outcomes with pathogen reduction technology
    Goodrich, Raymond P.
    Ettinger, Anna
    Radziwon, Piotr M.
    Rock, Gail
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2011, 45 (03) : 229 - 238
  • [2] The six questions of pathogen reduction technology: An overview of current opinions
    Solheim, Bjarte G.
    Seghatchian, Jerard
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2008, 39 (01) : 51 - 57
  • [3] Safety of the blood supply: role of pathogen reduction
    Wu, YY
    Snyder, EL
    [J]. BLOOD REVIEWS, 2003, 17 (02) : 111 - 122
  • [4] Improvement of Blood Processing and Safety by Automation and Pathogen Reduction Technology
    Perez Aliaga, Ana Isabel
    Labata, Gorka
    Aranda, Alfonso
    Cardoso, Marcia
    Puente, Fernando
    Domingo, Jose Maria
    Garces, Carmen
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2021, 48 (05) : 290 - 297
  • [5] Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology
    Yonemura, Susan
    Doane, Suzann
    Keil, Shawn
    Goodrich, Raymond
    Pidcoke, Heather
    Cardoso, Marcia
    [J]. BLOOD TRANSFUSION, 2017, 15 (04) : 357 - 364
  • [6] Viral safety of blood derivatives: An overview
    Horaud, F
    [J]. CLINICAL THERAPEUTICS, 1996, 18 : 37 - 42
  • [7] Highlights of PBTI Coimbra Conference on PRT of Plasma & Current Opinions on Pathogen Reduction Treatment of Blood Components
    de Sousa, Gracinda
    Seghatchian, Jerard
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2015, 52 (02) : 228 - 232
  • [8] Commentary on the current opinions on blood components safety/efficacy
    Seghatchian, Jerard
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2006, 34 (03) : 241 - 242
  • [9] Viral safety of blood derivatives by immune neutralization
    Rollag, H
    Solheim, BG
    Svennevig, JL
    [J]. VOX SANGUINIS, 1998, 74 : 213 - 217
  • [10] Safety improving by complementary serological and molecular testing combined with pathogen reduction of the donated blood in window period
    Balint, Bela
    Vucetic, Dusan
    Todorovic-Balint, Milena
    Borovcanin, Nemanja
    Jovanovic-Cupic, Snezana
    Mandusic, Vesna
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2013, 49 (01) : 103 - 104
12345